Inmazeb
Atoltivimab, maftivimab, and odesivimab-ebgn · Regeneron Pharmaceuticals, Inc.
PRESCRIPTION ONLY (USA)Inmazeb ingredients
| Active ingredient | Strength |
|---|---|
| Atoltivimab | 483.3 mg/14.5mL, 241.7 mg/14.5mL |
| Maftivimab | 483.3 mg/14.5mL, 241.7 mg/14.5mL |
| Odesivimab | 483.3 mg/14.5mL, 241.7 mg/14.5mL |
What Inmazeb is used for
Inmazeb is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Inmazeb
- Generic name
- Atoltivimab, maftivimab, and odesivimab-ebgn
- Made by
- Regeneron Pharmaceuticals, Inc.
- Forms
- Injection, Solution
- Given
- Intravenous
- FDA approval
- Biologic licence (BLA) BLA761169
- On the US market since
- 2020
Official information
- Inmazeb prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Atoltivimab, maftivimab, and odesivimab-ebgn)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Inmazeb?
Inmazeb (Atoltivimab, maftivimab, and odesivimab-ebgn) is a specialist medicine made by Regeneron Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Inmazeb?
Inmazeb contains Atoltivimab (483.3 mg/14.5mL, 241.7 mg/14.5mL); Maftivimab (483.3 mg/14.5mL, 241.7 mg/14.5mL); Odesivimab (483.3 mg/14.5mL, 241.7 mg/14.5mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA